16.12.2024 20:34:21 CET | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state
Oslo, Norway, 16 December 2024: Reference is made to stock exchange
announcements by Thor Medical ASA (the "Company") on 12 December 2024 regarding
the completion of a Company private placement and a retail offering. Completion
of tranche 2 of the private placement and a potential subsequent offering is
conditional on approval by the general meeting of the Company, as described in
the stock exchange announcement on 12 December 2024.
The Company hereby calls for an extraordinary general meeting in the Company to
be held on 6 January 2025 at 14:00 hours CET at Advokatfirmaet Selmer AS,
Ruseløkkveien 14, 0251 Oslo. The full notice is attached. The notice and the
documents to which it refers to are available on https://www.thormedical.no/.
DISCLOSURE REGULATION
This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.
CONTACTS
Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.no
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of alpha emitters enabling next generation
cancer treatments. Its proprietary production process requires no irradiation or
use of nuclear reactors, and provides reliable, environmentally friendly,
cost-efficient supply of alpha emitters for the radiopharmaceutical industry.
Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock
Exchange under the ticker symbol 'TRMED'.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18361963/5422/Download%20announce
ment%20as%20PDF.pdf
Thor Medical - Notice of EGM January 2025 - English.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18361963/5420/Thor%20Medical%20-%
20Notice%20of%20EGM%20January%202025%20-%20English.pdf
Thor Medical - Notice of EGM January 2025 - norsk.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18361963/5421/Thor%20Medical%20-%
20Notice%20of%20EGM%20January%202025%20-%20norsk.pdf